A bright future for dementia research
What do biomarkers mean for the treatment of Alzheimer’s disease?
Loss of presenilin function and Alzheimer’s disease
Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD
AMPK in Alzheimer’s Disease: a double-edged sword?